Kastenbauer S - Search Results

1

Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2.

Rupprecht TA, Kirschning CJ, Popp B, Kastenbauer S, Fingerle V, Pfister HW, Koedel U. Rupprecht TA, et al. Among authors: kastenbauer s. Infect Immun. 2007 Sep;75(9):4351-6. doi: 10.1128/IAI.01642-06. Epub 2007 Jun 11. Infect Immun. 2007. PMID: 17562761 Free PMC article.

2

The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.

Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U. Rupprecht TA, et al. Among authors: kastenbauer s. Neurology. 2005 Aug 9;65(3):448-50. doi: 10.1212/01.wnl.0000171349.06645.79. Neurology. 2005. PMID: 16087912

3

The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.

Rupprecht TA, Plate A, Adam M, Wick M, Kastenbauer S, Schmidt C, Klein M, Pfister HW, Koedel U. Rupprecht TA, et al. Among authors: kastenbauer s. J Neuroinflammation. 2009 Dec 30;6:42. doi: 10.1186/1742-2094-6-42. J Neuroinflammation. 2009. PMID: 20042073 Free PMC article.

4

Urate oxidation in CSF and blood of patients with inflammatory disorders of the nervous system.

Becker BF, Kastenbauer S, Ködel U, Kiesl D, Pfister HW. Becker BF, et al. Among authors: kastenbauer s. Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1201-4. doi: 10.1081/NCN-200027469. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15571231

5

NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression.

Kastenbauer S, Ziegler-Heitbrock HW. Kastenbauer S, et al. Infect Immun. 1999 Apr;67(4):1553-9. doi: 10.1128/IAI.67.4.1553-1559.1999. Infect Immun. 1999. PMID: 10084986 Free PMC article.

6

Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment.

Klein M, Koedel U, Kastenbauer S, Pfister HW. Klein M, et al. Among authors: kastenbauer s. Infection. 2008 Feb;36(1):2-14. doi: 10.1007/s15010-007-7153-1. Epub 2007 Dec 14. Infection. 2008. PMID: 18084715 Review.

7

Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy.

Kastenbauer S, Koedel U, Becker BF, Pfister HW. Kastenbauer S, et al. Eur J Pharmacol. 2002 Aug 2;449(1-2):177-81. doi: 10.1016/s0014-2999(02)01980-5. Eur J Pharmacol. 2002. PMID: 12163122

8

Experimental meningitis in the rat: protection by uric acid at human physiological blood concentrations.

Kastenbauer S, Koedel U, Becker BF, Pfister HW. Kastenbauer S, et al. Eur J Pharmacol. 2001 Aug 10;425(2):149-52. doi: 10.1016/s0014-2999(01)01137-2. Eur J Pharmacol. 2001. PMID: 11502281

9

Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis.

Kastenbauer S, Koedel U, Pfister HW. Kastenbauer S, et al. J Infect Dis. 1999 Oct;180(4):1164-70. doi: 10.1086/315048. J Infect Dis. 1999. PMID: 10479144

10

MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis.

Klein M, Schmidt C, Kastenbauer S, Paul R, Kirschning CJ, Wagner H, Popp B, Pfister HW, Koedel U. Klein M, et al. Among authors: kastenbauer s. J Infect Dis. 2007 Apr 15;195(8):1189-93. doi: 10.1086/512859. Epub 2007 Mar 5. J Infect Dis. 2007. PMID: 17357057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results